Establishing and augmenting views on the acceptability of a paediatric critical care randomised controlled trial (the FEVER trial): a mixed methods study.
medical education & training
paediatric intensive & critical care
paediatrics
pain management
qualitative research
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
10 03 2021
10 03 2021
Historique:
entrez:
11
3
2021
pubmed:
12
3
2021
medline:
20
5
2021
Statut:
epublish
Résumé
To explore parent and staff views on the acceptability of a randomised controlled trial investigating temperature thresholds for antipyretic intervention in critically ill children with fever and infection (the FEVER trial) during a multi-phase pilot study. Mixed methods study with data collected at three time points: (1) before, (2) during and (3) after a pilot trial. English, Paediatric Intensive Care Units (PICUs). (1) Pre-pilot trial focus groups with pilot site staff (n=56) and interviews with parents (n=25) whose child had been admitted to PICU in the last 3 years with a fever and suspected infection, (2) Questionnaires with parents of randomised children following pilot trial recruitment (n=48 from 47 families) and (3) post-pilot trial interviews with parents (n=19), focus groups (n=50) and a survey (n=48) with site staff. Analysis drew on Sekhon There was initial support for the trial, yet some held concerns regarding the proposed temperature thresholds and not using paracetamol for pain or discomfort. Pre-trial findings informed protocol changes and training, which influenced views on trial acceptability. Staff trained by the FEVER team found the trial more acceptable than those trained by colleagues. Parents and staff found the trial acceptable. Some concerns about pain or discomfort during weaning from ventilation remained. Pre-trial findings and pilot trial experience influenced acceptability, providing insight into how challenges may be overcome. We present an adapted theoretical framework of acceptability to inform future trial feasibility studies. ISRCTN16022198 and NCT03028818.
Identifiants
pubmed: 33692177
pii: bmjopen-2020-041952
doi: 10.1136/bmjopen-2020-041952
pmc: PMC7949453
doi:
Substances chimiques
Antipyretics
0
Banques de données
ClinicalTrials.gov
['NCT03028818']
ISRCTN
['ISRCTN16022198']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e041952Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: MJP is a member of the NIHR HTA Board. KMR is a member of the NIHR HS & DR Board.
Références
Crit Care. 2019 Mar 7;23(1):69
pubmed: 30845977
Health Technol Assess. 2018 Sep;22(51):1-106
pubmed: 30238870
Lancet. 2004 Aug 28-Sep 3;364(9436):803-11
pubmed: 15337409
Clin Dermatol. 2017 Nov - Dec;35(6):583-593
pubmed: 29191349
Trials. 2006 Dec 12;7:32
pubmed: 17163988
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
BMJ Open. 2015 Sep 18;5(9):e008522
pubmed: 26384724
J Pediatr. 2002 Dec;141(6):798-803
pubmed: 12461496
Eur J Pediatr. 2017 Mar;176(3):423-427
pubmed: 28097438
BMC Health Serv Res. 2017 Jan 26;17(1):88
pubmed: 28126032
Arch Dis Child. 2019 Nov;104(11):1077-1082
pubmed: 31175125
Int J Qual Stud Health Well-being. 2014 Oct 16;9:26152
pubmed: 25326092
Health Technol Assess. 2014 Jun;18(38):1-197, v-vi
pubmed: 24914457
BMC Public Health. 2013 Aug 15;13:756
pubmed: 23947336
Contemp Clin Trials Commun. 2017 Nov 23;9:33-39
pubmed: 29696222
Arch Dis Child. 2019 Oct;104(10):979-983
pubmed: 31175126
Milbank Q. 2001;79(4):613-39, v
pubmed: 11789119
Health Technol Assess. 2019 Feb;23(5):1-148
pubmed: 30793698
Trials. 2014 Oct 16;15:399
pubmed: 25322807
J Med Ethics. 2011 Jul;37(7):429-32
pubmed: 21345861
PLoS One. 2013;8(2):e54894
pubmed: 23408950
Arch Dis Child Educ Pract Ed. 2016 Feb;101(1):49-53
pubmed: 26464416
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
Arch Dis Child. 2019 May;104(5):426-431
pubmed: 30087153
BMJ Open. 2018 Jun 9;8(6):e022894
pubmed: 29886449
Trials. 2006 Apr 07;7:9
pubmed: 16603070
Cochrane Database Syst Rev. 2010 Jan 20;(1):MR000013
pubmed: 20091668